Understanding the Effect of Inflammation is
Key for Early Intervention, Reducing Adverse Cardiovascular
Outcomes
WASHINGTON, July 19,
2024 /PRNewswire/ -- The International
Atherosclerosis Society today released a clinical proceedings white
paper outlining the role of inflammation in atherosclerosis and the
importance of early intervention.
The paper has four main sections:
- The role of inflammation in atherosclerosis is
explained, noting that local inflammation in the artery wall
participates directly in the development of the condition.
Systemic, chronic inflammation can also promote the advancement of
atherosclerosis and increase the risk of developing cardiovascular
diseases.
- Using biomarkers to identify inflammatory risk in
individual patients is now possible. Assessing levels of
high-sensitivity CRP specifically can be used to help determine
therapeutic strategies that may reduce the risk of major
cardiovascular events.
- Interventions that may mitigate inflammatory
risk include lifestyle modifications as well as
pharmaceutical interventions. Policy changes could also mitigate
the inflammatory risk of atherosclerosis.
- The burdens of disease are
substantial. Atherosclerosis results in significant loss of
life and greatly impacts household finances and economies
worldwide.
Assessment & Treatment of Inflammation in
Atherosclerosis is authored by four international experts:
- Peter Libby, MD – USA
- Wolfgang Koenig, MD, FRCP, FESC,
FACC, FAHA – Germany
- Jessica M. Peña, MD, MPH, FACC, FNLA – USA
- Hiroaki Shimokawa, MD, PhD –
Japan
READ WHITE PAPER: Assessment & Treatment of
Inflammation in Atherosclerosis
STATEMENT FROM PETER LIBBY,
MD, PRESIDENT, INTERNATIONAL ATHEROSCLEROSIS SOCIETY AND CHAIR OF
THE WHITE PAPER EXPERT PANEL:
"Atherosclerosis is a primary
cause of cardiovascular disease, the leading cause of death
worldwide. This paper underscores the persistent need for a more
complete understanding of the role of inflammation in
atherosclerosis progression among physicians globally, how to
identify such inflammation, and how to mitigate the
inflammation-associated risk of adverse cardiovascular events.
These steps are of the utmost importance for the development of
effective treatment strategies that can reduce the morbidity and
mortality caused by atherosclerotic cardiovascular disease."
View original
content:https://www.prnewswire.com/news-releases/new-paper-underscores-inflammations-role-in-atherosclerosis-302201031.html
SOURCE International Atherosclerosis Society